# Workday, Inc.: financial statements, quarterly

WDAY · Nasdaq · CIK 1327811 · [Technology](/sectors/technology.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/wday.md) · [Financials](/companies/wday/financials.md) · [Filings](/companies/wday/filings.md) · [Insiders](/companies/wday/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wday/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,866](/filings/0001327811-24-000242.md) | [1,922 d](/filings/0001327811-26-000014.md) | [1,990](/filings/0001327811-25-000107.md) | [2,085](/filings/0001327811-25-000184.md) | [2,160](/filings/0001327811-25-000198.md) | [2,211 d](/filings/0001327811-26-000014.md) | [2,240](/filings/0001327811-26-000026.md) | [2,348](/filings/0001327811-26-000044.md) | [2,432](/filings/0001327811-25-000198.md) | [2,532 d](/filings/0001327811-26-000014.md) | [2,542](/filings/0001327811-26-000026.md) | [2,649](/filings/0001327811-26-000044.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [619](/filings/0001327811-24-000242.md) | [635 d](/filings/0001327811-26-000014.md) | [656](/filings/0001327811-25-000107.md) | [649](/filings/0001327811-25-000184.md) | [647](/filings/0001327811-25-000198.md) | [674 d](/filings/0001327811-26-000014.md) | [663](/filings/0001327811-26-000026.md) | [660](/filings/0001327811-26-000044.md) | [666](/filings/0001327811-25-000198.md) | [691 d](/filings/0001327811-26-000014.md) | [705](/filings/0001327811-26-000026.md) | [747](/filings/0001327811-26-000044.md) |
| Operating income | $m | [88.0](/filings/0001327811-24-000242.md) | [79.0 d](/filings/0001327811-26-000014.md) | [64.0](/filings/0001327811-25-000107.md) | [111](/filings/0001327811-25-000184.md) | [165](/filings/0001327811-25-000198.md) | [75.0 d](/filings/0001327811-26-000014.md) | [39.0](/filings/0001327811-26-000026.md) | [248](/filings/0001327811-26-000044.md) | [259](/filings/0001327811-25-000198.md) | [174 d](/filings/0001327811-26-000014.md) | [338](/filings/0001327811-26-000026.md) | [313](/filings/0001327811-26-000044.md) |
| Interest expense | $m | [28.5](/filings/0001327811-23-000202.md) | [28.4 d](/filings/0001327811-24-000044.md) | [29.0](/filings/0001327811-24-000093.md) | [28.0](/filings/0001327811-25-000184.md) | [29.0](/filings/0001327811-25-000198.md) | [28.0 d](/filings/0001327811-26-000014.md) | [29.0](/filings/0001327811-26-000026.md) | [29.0](/filings/0001327811-26-000044.md) | [29.0](/filings/0001327811-25-000198.md) | [28.0 d](/filings/0001327811-26-000014.md) | [26.0](/filings/0001327811-26-000026.md) | [28.0](/filings/0001327811-26-000044.md) |
| Income tax | $m | [15.0](/filings/0001327811-24-000242.md) | [(1,050) d](/filings/0001327811-26-000014.md) | [16.0](/filings/0001327811-25-000107.md) | [36.0](/filings/0001327811-25-000184.md) | [34.0](/filings/0001327811-25-000198.md) | [26.0 d](/filings/0001327811-26-000014.md) | [35.0](/filings/0001327811-26-000026.md) | [76.0](/filings/0001327811-26-000044.md) | [86.0](/filings/0001327811-25-000198.md) | [119 d](/filings/0001327811-26-000014.md) | [133](/filings/0001327811-26-000026.md) | [(305)](/filings/0001327811-26-000044.md) |
| Net income | $m | [114](/filings/0001327811-24-000242.md) | [1,188 d](/filings/0001327811-26-000014.md) | [107](/filings/0001327811-25-000107.md) | [132](/filings/0001327811-25-000184.md) | [193](/filings/0001327811-25-000198.md) | [94.0 d](/filings/0001327811-26-000014.md) | [68.0](/filings/0001327811-26-000026.md) | [228](/filings/0001327811-26-000044.md) | [252](/filings/0001327811-25-000198.md) | [145 d](/filings/0001327811-26-000014.md) | [222](/filings/0001327811-26-000026.md) | [632](/filings/0001327811-26-000044.md) |
| Diluted EPS | $ per share | [0.43](/filings/0001327811-24-000242.md) | not reported | [0.40](/filings/0001327811-25-000107.md) | [0.49](/filings/0001327811-25-000184.md) | [0.72](/filings/0001327811-25-000198.md) | not reported | [0.25](/filings/0001327811-26-000026.md) | [0.84](/filings/0001327811-26-000044.md) | [0.94](/filings/0001327811-25-000198.md) | not reported | [0.87](/filings/0001327811-26-000026.md) | [2.57](/filings/0001327811-26-000044.md) |
| Basic EPS | $ per share | [0.43](/filings/0001327811-24-000242.md) | not reported | [0.40](/filings/0001327811-25-000107.md) | [0.50](/filings/0001327811-25-000184.md) | [0.73](/filings/0001327811-25-000198.md) | not reported | [0.25](/filings/0001327811-26-000026.md) | [0.86](/filings/0001327811-26-000044.md) | [0.95](/filings/0001327811-25-000198.md) | not reported | [0.87](/filings/0001327811-26-000026.md) | [2.58](/filings/0001327811-26-000044.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-10-31) | FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.6](/filings/0001327811-24-000242.md) | [2.0](/filings/0001327811-26-000014.md) | [1.8](/filings/0001327811-25-000107.md) | [1.6](/filings/0001327811-25-000184.md) | [1.3](/filings/0001327811-25-000198.md) | [1.5](/filings/0001327811-26-000014.md) | [1.0](/filings/0001327811-26-000026.md) | [1.3](/filings/0001327811-26-000044.md) | [2.6](/filings/0001327811-25-000198.md) | [1.5](/filings/0001327811-26-000044.md) | [0.6](/filings/0001327811-26-000026.md) | [0.7](/filings/0001327811-26-000044.md) |
| Current assets | $bn | [8.6](/filings/0001327811-23-000202.md) | [9.9](/filings/0001327811-25-000056.md) | [8.9](/filings/0001327811-24-000093.md) | [9.2](/filings/0001327811-24-000165.md) | [9.1](/filings/0001327811-24-000242.md) | [10.5](/filings/0001327811-26-000014.md) | [10.0](/filings/0001327811-25-000107.md) | [10.4](/filings/0001327811-25-000184.md) | [9.2](/filings/0001327811-25-000198.md) | [8.4](/filings/0001327811-26-000044.md) | [6.6](/filings/0001327811-26-000026.md) | [6.0](/filings/0001327811-26-000044.md) |
| Total assets | $bn | [13.9](/filings/0001327811-23-000202.md) | [16.5](/filings/0001327811-25-000056.md) | [15.9](/filings/0001327811-24-000093.md) | [16.2](/filings/0001327811-24-000165.md) | [16.4](/filings/0001327811-24-000242.md) | [18.0](/filings/0001327811-26-000014.md) | [17.2](/filings/0001327811-25-000107.md) | [18.0](/filings/0001327811-25-000184.md) | [17.8](/filings/0001327811-25-000198.md) | [18.1](/filings/0001327811-26-000044.md) | [16.1](/filings/0001327811-26-000026.md) | [15.9](/filings/0001327811-26-000044.md) |
| Current liabilities | $bn | [4.0](/filings/0001327811-23-000202.md) | [5.1](/filings/0001327811-25-000056.md) | [4.4](/filings/0001327811-24-000093.md) | [4.5](/filings/0001327811-24-000165.md) | [4.4](/filings/0001327811-24-000242.md) | [5.5](/filings/0001327811-26-000014.md) | [4.8](/filings/0001327811-25-000107.md) | [4.9](/filings/0001327811-25-000184.md) | [5.0](/filings/0001327811-25-000198.md) | [6.4](/filings/0001327811-26-000044.md) | [6.5](/filings/0001327811-26-000026.md) | [6.6](/filings/0001327811-26-000044.md) |
| Total liabilities | $bn | [7.3](/filings/0001327811-23-000202.md) | [8.4](/filings/0001327811-25-000056.md) | [7.8](/filings/0001327811-24-000093.md) | [7.9](/filings/0001327811-24-000165.md) | [7.8](/filings/0001327811-24-000242.md) | [8.9](/filings/0001327811-26-000014.md) | [8.3](/filings/0001327811-25-000107.md) | [8.8](/filings/0001327811-25-000184.md) | [8.9](/filings/0001327811-25-000198.md) | [10.3](/filings/0001327811-26-000044.md) | [9.4](/filings/0001327811-26-000026.md) | [9.4](/filings/0001327811-26-000044.md) |
| Long-term debt | $bn | [3.0](/filings/0001327811-23-000202.md) | [3.0](/filings/0001327811-25-000056.md) | [3.0](/filings/0001327811-24-000093.md) | [3.0](/filings/0001327811-24-000165.md) | [3.0](/filings/0001327811-24-000242.md) | [3.0](/filings/0001327811-26-000014.md) | [3.0](/filings/0001327811-25-000107.md) | [3.0](/filings/0001327811-25-000184.md) | [3.0](/filings/0001327811-25-000198.md) | [3.0](/filings/0001327811-26-000044.md) | [2.0](/filings/0001327811-26-000026.md) | [2.0](/filings/0001327811-26-000044.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001327811-26-000044.md) | [1.0](/filings/0001327811-26-000026.md) | [1.0](/filings/0001327811-26-000044.md) |
| Shareholders' equity | $bn | [6.6](/filings/0001327811-24-000242.md) | [8.1](/filings/0001327811-26-000014.md) | [8.2](/filings/0001327811-25-000107.md) | [8.3](/filings/0001327811-25-000184.md) | [8.6](/filings/0001327811-25-000198.md) | [9.0](/filings/0001327811-26-000014.md) | [8.9](/filings/0001327811-26-000026.md) | [9.2](/filings/0001327811-26-000044.md) | [8.9](/filings/0001327811-25-000198.md) | [7.8](/filings/0001327811-26-000044.md) | [6.7](/filings/0001327811-26-000026.md) | [6.5](/filings/0001327811-26-000044.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [451](/filings/0001327811-24-000242.md) | [996 d](/filings/0001327811-26-000014.md) | [372](/filings/0001327811-25-000107.md) | [571](/filings/0001327811-24-000165.md) | [406](/filings/0001327811-24-000242.md) | [1,112 d](/filings/0001327811-26-000014.md) | [457](/filings/0001327811-26-000026.md) | [616 d](/filings/0001327811-26-000044.md) | [588 d](/filings/0001327811-25-000198.md) | [1,278 d](/filings/0001327811-26-000014.md) | [696](/filings/0001327811-26-000026.md) | [519 d](/filings/0001327811-26-000044.md) |
| Capital expenditure | $m | [60.0](/filings/0001327811-24-000242.md) | [49.0 d](/filings/0001327811-26-000014.md) | [81.0](/filings/0001327811-25-000107.md) | [55.0](/filings/0001327811-24-000165.md) | [47.0](/filings/0001327811-24-000242.md) | [86.0 d](/filings/0001327811-26-000014.md) | [36.0](/filings/0001327811-26-000026.md) | [28.0 d](/filings/0001327811-26-000044.md) | [38.0 d](/filings/0001327811-25-000198.md) | [60.0 d](/filings/0001327811-26-000014.md) | [80.0](/filings/0001327811-26-000026.md) | [59.0 d](/filings/0001327811-26-000044.md) |
| Share repurchases | $m | [145](/filings/0001327811-24-000242.md) | [140 d](/filings/0001327811-26-000014.md) | [128](/filings/0001327811-25-000107.md) | [312](/filings/0001327811-24-000165.md) | [158](/filings/0001327811-24-000242.md) | [103 d](/filings/0001327811-26-000014.md) | [290](/filings/0001327811-26-000026.md) | [299 d](/filings/0001327811-26-000044.md) | [802 d](/filings/0001327811-25-000198.md) | [1,504 d](/filings/0001327811-26-000014.md) | [1,587](/filings/0001327811-26-000026.md) | [1,337 d](/filings/0001327811-26-000044.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2022-10-31) | Q1 FY2024 (2023-04-30) | Q2 FY2024 (2023-07-31) | Q3 FY2024 (2023-10-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [256](/filings/0001327811-23-000202.md) | [261](/filings/0001327811-24-000093.md) | [264](/filings/0001327811-24-000165.md) | [266](/filings/0001327811-24-000242.md) | [270](/filings/0001327811-25-000107.md) | [268](/filings/0001327811-25-000184.md) | [269](/filings/0001327811-25-000198.md) | [270](/filings/0001327811-26-000026.md) | [270](/filings/0001327811-26-000044.md) | [269](/filings/0001327811-25-000198.md) | [254](/filings/0001327811-26-000026.md) | [246](/filings/0001327811-26-000044.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 220,000,000 at 2018-11-30, from the cover of the [10-Q filed 2018-12-03](/filings/0001327811-18-000058.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.